BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis
BRCA1/2 和其他易感基因在接受内分泌治疗（含或不含帕博西尼）的高危激素受体阳性/人表皮生长因子受体 2 阴性乳腺癌患者中的作用：一项 PENELOPE-B 研究的二次分析
期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO-24-00742
Hahnen, Eric; Hauke, Jan; Gelmon, Karen; Marmé, Frederik; Ernst, Corinna; Martin, Miguel; Untch, Michael; Bonnefoi, Hervé; Knudsen, Erik; Im, Seock-Ah; DeMichele, Angela; Van't Veer, Laura; Kim, Sung-Bae; Bear, Harry; McCarthy, Nicole; Rhiem, Kerstin; Turner, Nicholas; Witkiewicz, Agnieszka; Rojo, Federico; Filipits, Martin; Martin, Lesley-Ann; Fasching, Peter A; Schem, Christian; Becker, Kerstin; García-Sáenz, José A; Kelly, Catherine M; Reimer, Toralf; Toi, Masakazu; Rugo, Hope S; Denkert, Carsten; Gnant, Michael; Makris, Andreas; Liu, Yuan; Valota, Olga; Felder, Bärbel; Weber, Karsten; Nekljudova, Valentina; Loibl, Sibylle
肿瘤
肿瘤免疫
信号转导
乳腺癌
BRCA1
Human
免疫/内分泌
